Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.280
-0.050 (-2.15%)
At close: Oct 15, 2025, 4:00 PM EDT
2.240
-0.040 (-1.75%)
Pre-market: Oct 16, 2025, 7:00 AM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $138.11 million as of October 16, 2025. Its market cap has decreased by -7.31% in one year.
Market Cap
138.11M
Enterprise Value
2.04M
1-Year Change
-7.31%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $138.11M, a decrease of -77.67%. That is a compound annual growth rate of -29.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 138.11M | 33.65% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.82B |
| Johnson & Johnson | 460.62B |
| AbbVie | 399.98B |
| UnitedHealth Group | 325.70B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.63B |